← Back to Search

Microfluidics Device

ZyMot Multi Sperm Separation Device (850 ul) for Assisted Reproductive Technology

N/A
Waitlist Available
Led By Rani Fritz, DO, PhD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Use or possible use of ICSI for oocyte insemination
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up culture day 5 or 6
Awards & highlights

Study Summary

This trial will compare the success of two different methods of separating sperm for ICSI.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You may have used or plan to use a specific method called ICSI for fertilization of eggs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~culture day 5 or 6
This trial's timeline: 3 weeks for screening, Varies for treatment, and culture day 5 or 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Good Quality Blastocyst Formation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ZyMot SeparationExperimental Treatment1 Intervention
Treatment
Group II: Density Gradient CentrifugationActive Control1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ZyMot Multi Sperm Separation Device (850 ul)
2021
N/A
~110

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,358 Previous Clinical Trials
816,705 Total Patients Enrolled
Rani Fritz, DO, PhDPrincipal InvestigatorNYU Langone Health

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available for individuals to join this clinical endeavor?

"Data available on clinicaltrials.gov suggests that the recruitment phase of this trial is complete; it was first published on June 18th 2021 and last updated 6/6/2022. However, there are presently 9 other trials actively seeking patients at this time."

Answered by AI

Who else is applying?

What site did they apply to?
NYU Langone Reproductive Specialists of NY
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

don't want to provide my SSN to a random website.
PatientReceived 2+ prior treatments
~29 spots leftby Mar 2025